Skip to content
SentinelMarket desk
Switch to dark mode

영진약품

003520KOSPIView the 제약 sectorTheme Bio & healthcare

1,013KRWMarket close of 10/20 (Tue)

Down -1.94%-20KRWMarket close of 10/20 (Tue)

Preliminary value right after the close — replaced by official KRX data tomorrow morningClose of 10/21 (Wed)1,003KRWDown -0.99%

Preliminary · just after the close · replaced by official KRX data tomorrow morning

Open
1,037
High
1,048
Low
1,010
Day range
Day range low 1,010 high 1,048, open 1,037, close 1,013, previous close 1,033
Volume
18×10K shares
183.17 million KRW 0.48× the 20-session average

Market close of 10/20 (Tue)

Where it sits in the 1-year range

1-year close range 996 to 2,170 won, 1% up from the low

1% of the way up from the lowest close in 1 year (252 sessions) · -53.3% from the high

Usual range

Nothing unusual in the 3 checked items

Free · no sign-inSource from 2021-05-17

Points to check

  • Earningsnot verifiedOutside financial data coverage, so not verified
  • Recent filingsnot verifiedOutside filing data coverage, so not verified
  • Foreign & institutionalnot verifiedOutside investor-flow coverage, so not verified

The other 3 are within the usual range

  • Daily move-1.94%usual range
  • Trading value0.5×usual range
  • Data date10/20 (Tue)Market close
See the full check report

Same sector · 제약

Down -1.68%

· 29 of 168 stocks up, preferred shares excluded · trading value 827.8B KRW

Same sector · top by trading value
Stock20DChangeTrading value
셀트리온Close over the last 20 sessions +11.4%Down -0.40%139.2B KRW
삼성바이오로직스Close over the last 20 sessions -1.3%Down -2.52%129.9B KRW
삼익제약Close over the last 20 sessions -20.4%Up +2.77%76.0B KRW
녹십자엠에스Close over the last 20 sessions +30.5%Up +6.67%55.6B KRW
유한양행Close over the last 20 sessions +11.5%Down -1.37%41.6B KRW

Schedule

  • Next data 10/22 (Thu) after 08:50

Investor flows, financials and valuation are provided for 369 stocks. These stocks account for about 81% of trading value, about 92% of market capitalisation. Coverage status →

For information only, not a solicitation to invest. Investment decisions and their results are your own responsibility.